Heart safety study finds no major risks from inhaled drug
NCT ID NCT00874237
First seen Apr 30, 2026 · Last updated May 20, 2026 · Updated 6 times
Summary
This study looked at whether Staccato Loxapine, an inhaled drug, affects the heart's electrical activity in 48 healthy volunteers. Participants received the drug, a placebo, and another control in a crossover design. The goal was to measure changes in heart rhythm, not to treat any disease. The study was completed and provides safety data for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THOROUGH QT/QTC STUDY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Covance Clinical Research Unit Inc.
Evansville, Indiana, 47710, United States
Conditions
Explore the condition pages connected to this study.